Literature DB >> 12271239

The cost-effectiveness of wound management protocols of care.

K Harding1, K Cutting, P Price.   

Abstract

A European cost-effectiveness study has been conducted using published clinical trial data from multinational studies on chronic venous leg ulcers and pressure sores. Data relevant to UK chronic wound management practice have been extracted and are presented here. A total of 15 pressure sore studies involving 519 wounds, and 12 leg ulcer studies involving 843 ulcers were used in a pooled analysis. The study objectives included the calculation of comparative costs in pound sterling for three different treatment protocols for each wound type. The protocols have been adapted for UK clinical practice in both hospital and community settings and are based on primary dressings and nurse time costs, wound cleansing and debridement, the use of fillers, and compression as appropriate. The focus of the study has been the cost-effectiveness comparison (as measured by cost per healed wound) of two modern dressings - Granuflex(R) hydrocolloid dressing and Apligraf(R) skin replacement - and traditional gauze dressings in the treatment of venous leg ulcers and, in the case of pressure sores, comparison of Granuflex(R) Comfeel(R) hydrocolloid dressings and traditional saline gauze dressings. The choice of dressings studied was dictated by the available published literature. The construction of treatment protocols and assumptions on treatments otherwise missing from published papers has been achieved through the use of an expert panel. Results show Granuflex(R) to be 50% more cost-effective, at 422 pounds per healed wound, than Comfeel(R) (643 pounds) and 500% more so than saline gauze (2548 pounds) in the treatment of pressure sores. Granuflex(R) at 342 pounds was also more cost-effective than gauze (541 pounds) or Apligraf(R) (6741 pounds) in the treatment of venous leg ulcers. These data will provide a valuable adjunct to published clinical evidence, offering further information upon which carers can base their choice of wound dressing.

Entities:  

Mesh:

Year:  2000        PMID: 12271239     DOI: 10.12968/bjon.2000.9.Sup3.12483

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  13 in total

Review 1.  Dressings and topical agents for treating pressure ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Marta O Soares; Nikki Stubbs; Gill Norman
Journal:  Cochrane Database Syst Rev       Date:  2017-06-22

Review 2.  Gauze packing of open surgical wounds: empirical or evidence-based practice?

Authors:  F Dinah; A Adhikari
Journal:  Ann R Coll Surg Engl       Date:  2006-01       Impact factor: 1.891

Review 3.  Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery.

Authors:  David C G Sainsbury
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

4.  Negative pressure wound therapy in complex cranio-maxillofacial and cervical wounds.

Authors:  Giorgio Novelli; Francesco Daleffe; Gisella Birra; Gabriele Canzi; Fabio Mazzoleni; Pietro Boni; Clara Maino; Carlo Giussani; Davide Sozzi; Alberto Bozzetti
Journal:  Int Wound J       Date:  2017-11-23       Impact factor: 3.315

Review 5.  Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.

Authors:  Astrid Langer; Wolf Rogowski
Journal:  BMC Health Serv Res       Date:  2009-07-10       Impact factor: 2.655

6.  Wound bed preparation and oxygen balance--a new component?

Authors:  R Gary Sibbald; Kevin Y Woo; Douglas Queen
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

7.  The cost of managing diabetic foot ulceration in an Irish hospital.

Authors:  D Smith; M J Cullen; J J Nolan
Journal:  Ir J Med Sci       Date:  2004 Apr-Jun       Impact factor: 1.568

8.  A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693].

Authors:  Mohammad Taghi Hollisaz; Hossein Khedmat; Fatemeh Yari
Journal:  BMC Dermatol       Date:  2004-12-15

9.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

Review 10.  A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.

Authors:  Larissa Zaulyanov; Robert S Kirsner
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.